Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection
May 22, 2025
Medical Diagnostics & Screening
-
-
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra
March 27, 2025
-
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch
March 25, 2025
-
CENTOGENE Closes Strategic Transaction with Private Equity Group Charme Capital Partners
March 12, 2025
-
Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula
March 7, 2025
-
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
March 3, 2025
-
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market
February 7, 2025
-
Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock
February 7, 2025
-
Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch
February 7, 2025
-
DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base
February 6, 2025
-
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
January 27, 2025
-
CENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners
November 13, 2024
-
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
October 15, 2024
-
23andMe Announces 1-for-20 Reverse Stock Split
October 11, 2024
-
Angle PLC Announces 100th Publication Supporting Parsortix System Use
September 26, 2024
-
Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
August 19, 2024